Environmental Clean Technologies (ASX:ECT) just built a PFAS rig 18 times more powerful

Dropping the biochar additive and shrinking the kit 75% finally makes in-situ remediation a real field play

Environmental Clean Technologies (ASX:ECT) has done something it has not often managed in its corporate life. It has put a piece of hardware on the ground that looks ready to leave the laboratory.

The company has finished building a pilot Rapid Electrothermal Mineralisation system, or REM. In plain English, REM is a way of using a powerful electric current to heat contaminated soil above 1,000 degrees and destroy PFAS, the so-called forever chemicals that water utilities and defence sites have spent the past decade trying to clean up.

The pilot unit delivers 22 kW of power, roughly 18 times the output of the lab prototype, and it runs at 170 kHz and 2,200 V rather than the old 70 kHz and 500 V. That jump is the part that matters. It is the difference between a science experiment and a system you can actually drag onto a contaminated site.

The company is now targeting a first in-field demonstration in the second half of 2026. After two decades of incremental technology stories from ECT, this is the most concrete commercialisation step we have seen the company take in years.

We actually cover ECT in more depth here at PSR, which you can see in our research note here 

Why losing the biochar additive is the quiet breakthrough here

The old lab version of REM needed conductive additives, usually biochar, mixed into the soil so the current had something to travel through. That works fine on a benchtop. It does not work when the contaminated site is a 20-hectare former firefighting training ground.

By pushing frequency up to 170 kHz, the new system can carry current through soil on its own, without anyone needing to mix additives into the ground first. ECT claims no other PFAS remediation process has demonstrated additive-free, high-temperature in-situ treatment at this scale.

If that claim holds up under field validation, it is genuinely differentiated. Most competing PFAS solutions either dig the soil up and treat it ex-situ, or they capture PFAS on granular activated carbon and then ship the carbon somewhere else for incineration. Treating soil in place, without trucks, is a different commercial proposition entirely.

The deployability story is what changes the licensing pitch

ECT has cut the system volume by about 50% and the weight by 75% compared with the laboratory configuration. That sounds like a spec sheet detail. It is actually the entire commercial strategy.

Management has been clear that REM will be commercialised through licensing and OEM partnerships, with modular units bolted onto standard agricultural and construction equipment that contractors already own. You cannot mount a fixed laboratory rig onto an excavator. You can mount a 75% lighter pilot unit, and you can ask a remediation contractor to pay a per-tonne licence fee for the privilege.

The parallel GAC pathway, where the same hardware destroys PFAS captured on activated carbon from water treatment plants, doubles the addressable market without doubling the engineering work. The peer-reviewed validation using US Army Corps of Engineers samples gives that pathway a credibility anchor most ASX cleantech stories never get.

The execution risk that still sits across the whole thesis

We think investors should be honest about what has and has not been demonstrated. The pilot system exists, but field validation has not happened yet. The 96% demineralisation and 99.98% PFOA removal numbers were achieved in the lab, not in a paddock in the Latrobe Valley.

Replicating laboratory efficiency in heterogeneous, wet, variable real-world soil is the hurdle every in-situ remediation technology has tripped over. ECT is no exception until proven otherwise. The H2 2026 timeline gives the market roughly six months of waiting before the first real data point arrives.

Worth noting too that this is a separate technology track from the COLDry lignite work that RSM was brought in to review. ECT is now asking investors to back two parallel commercialisation stories, which spreads management focus and capital across more fronts than a microcap usually handles cleanly.

The Investors Takeaway for Environmental Clean Technologies

The pilot system is the first piece of hard evidence that REM can move out of Rice University and onto a contaminated site. Building it was the easy part. Proving it works in the field, at lab-equivalent efficiencies, on commercial PFAS samples, is the test that will determine whether licensing conversations turn into signed agreements.

If the H2 2026 field demonstration delivers, ECT walks into 2027 with a genuinely differentiated remediation platform, two commercial pathways, and an OEM integration model that does not require huge capex from licensees. If it stumbles, the company is back to talking about pilot data on slide decks. Investors looking to track how this fits alongside the COLDry review can read our earlier coverage of the broader ECT story at stocksdownunder.

Pitt Street Research Directors owns shares in the company discussed. This article reflects personal views and is not financial advice.